glp-1 jackson Compounded FAQ Good News: GLP-1 Medications in

As a result of these mechanisms, GLP-1 agonists stabilize mitochondrial function, prevent oxidative damage to lipids, proteins, and DNA, and preserve the integrity of cellular structures in vital organs, including the heart, kidneys, endothelium, and immune cells, which is crucial for preventing organ complications in sepsis

Phase 3 clinical trial data has shown a 60% reduction in heavy drinking days among participants taking GLP-1 medications

Extracellular vesicle-based interorgan transport of mitochondria from energetically stressed adipocytes

[DOI] [PubMed] [Google Scholar] 2.Bommer C., Sagalova V., Heesemann E., Manne-Goehler J., Atun R., Brnighausen T., Davies J., Vollmer S

Diabetes Care 32:18801886 Troke RC, Tan TM, Bloom SR (2014) The future role of gut hormones in the treatment of obesity

Current FDA-Approved Weight Loss Medications: GLP-1 and Dual Agonists (Most Effective): Tirzepatide (Zepbound) Approval: November 2023 Mechanism: Dual GIP/GLP-1 receptor agonist Average Weight Loss: 15-22% of body weight Administration: Weekly injection Semaglutide (Wegovy) Approval: June 2021 Mechanism: GLP-1 receptor agonist Average Weight Loss: 10-15% of body weight Administration: Weekly injection Liraglutide (Saxenda) Approval: December 2014 Mechanism: GLP-1 receptor agonist Average Weight Loss: 5-8% of body weight Administration: Daily injection Older Weight Loss Medications (Less Effective): Phentermine-Topiramate (Qsymia) Approval: July 2012 Mechanism: Appetite suppressant + anticonvulsant Average Weight Loss: 7-9% of body weight Administration: Daily pill Naltrexone-Bupropion (Contrave) Approval: September 2014 Mechanism: Opioid antagonist + antidepressant Average Weight Loss: 4-5% of body weight Administration: Daily pill Orlistat (Xenical, Alli) Approval: April 1999 (prescription), 2007 (OTC) Mechanism: Lipase inhibitor (blocks fat absorption) Average Weight Loss: 3-5% of body weight Administration: Three times daily with meals Phentermine (Adipex-P, Lomaira) Approval: 1959 Mechanism: Appetite suppressant Average Weight Loss: 5-7% of body weight Administration: Daily pill Restriction: Short-term use only (12 weeks) Effectiveness Ranking: Why GLP-1 Medications Dominate: The top three most effective medications are all GLP-1 receptor agonists